Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection — FDA Drug Shortage

Current — Hospira, Inc., A Pfizer Company

The FDA lists a drug shortage record for Bupivacaine Hydrochloride, Epinephrine Bitartrate Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Feb 20, 2018. Reported reason: Other

Shortage details

Status
Current
Company
Hospira, Inc., A Pfizer Company
Package NDC
0409-9042-17
Dosage Form
Injection
Presentation
Bupivacaine Hydrochloride with Epinephrine, Injection, 75 mg/30 mL (2.5 mg/mL) (NDC 0409-9042-17)
Initial Posting
Feb 20, 2018

Reason

Other

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.